WOMEN, LIFE AND SCIENCE CONFERENCE 2024

APRIL 30, 2024

8:00 am to 5:30 pm

GREENVILLE, SC

Elev8Cure Foundation is pleased to be the coordinating sponsor for this first annual Women, Life and Science Conference.

This all day conference will place focus on accelerating and empowering women in all stages – whether women entrepreneurs, women in executive and leadership roles, women founders and young professionals - hear from seasoned women leaders and professionals in venture capital, lifescience, biotechnology, medicine, executive coach and philanthropy; tell their story, provide ‘pearls’ of wisdom and of course, opportunities for strategic partnerships. 

REGISTRATION HERE!

October 19, 2020

Free Zoom WEBINAR

09:00 AM Pacific Time

11:00 AM Central Time

12:00 PM Eastern Time

Presented by :

LAURA QM CHOW, MD, FRCPC

Professor, Department of Oncology

Associate Chair of Education, Department of Oncology

Director of the Lung, Head and Neck and Clinical Immunotherapy Programs

Associate Director for Clinical Research, LIVESTRONG Cancer Institutes

Dell Medical School  |  The University of Texas at Austin

Faculty Bio

Laura Chow is a professor of oncology with tenure and the associate chair of education in the Department of Oncology at Dell Medical School. She is also director of thoracic, head and neck malignancies and clinical immunotherapy programs and the associate director of clinical research at Livestrong Cancer Institutes. Previously, Chow spent more than nine years as the associate director of the phase I developmental therapeutics program and attending medical oncologist in lung, head and neck malignancies at Seattle Cancer Care Alliance; associate member of clinical research at the Fred Hutchinson Cancer Research Center; and a professor in the Department of Medicine, Division of Oncology at the University of Washington. Chow came to medicine with a background in pharmacology and therapeutics and was inspired to pursue a career in oncology because of her personal experiences with cancer in her family as well as her interest in clinical research.

Chow has extensive clinical trials experience; a strong background in clinical pharmacology, therapeutics and developmental therapeutics; and excellent Canadian and USA internal medicine and clinical medical oncology skills and training.  Her clinical expertise is in head and neck cancers, thyroid cancer and lung cancers and a national international reputation as a researcher focused on novel therapeutics and early phase clinical trials, immunotherapy and head and neck cancers, thyroid cancers and lung cancers.  She has helped develop and bring forth many novel drugs, including the PD-1 immune-checkpoint inhibitors, into regulatory approval as standard-of-care treatments for head and neck cancers and lung cancer.  She has been the lead principal investigator of over 40 early phase thoracic and head and neck cancer trials with over 65 publications in high-impact journals, with a clinical research interest focused on developing novel lung and head and neck cancer immune-checkpoint therapies and new combination immunotherapeutics.